Astellas, Poseida Announce Investment To Support Poseida's Commitment To Cancer Cell Therapy

RTTNews | Před 581 dny
Astellas, Poseida Announce Investment To Support Poseida's Commitment To Cancer Cell Therapy

(RTTNews) - Pharmaceutical companies Astellas Pharma Inc. (ALPMY.PK) and Poseida Therapeutics, Inc. (PSTX) announced Monday a strategic investment to support the advancement of Poseida's commitment to redefining cancer cell therapy.

Under the terms of the transaction agreements, Astellas will invest a total of $50 million, including $25 million to acquire 8.3 million shares of common stock of Poseida or approximately 8.8% of the outstanding common stock of Poseida, at $3.00 per share in a private placement.

It will also make a one-time $25 million payment for a right of exclusive negotiation and first refusal to license one of Poseida's clinical stage programs: P-MUC1C-ALLO1, an allogeneic CAR-T cell therapy in development for multiple solid tumor indications.

In addition, Poseida has granted Astellas a board observer seat, which includes the ability to attend Poseida's scientific advisory board meetings, and certain notice rights related to any potential change of control of Poseida.

read more
Astellas Pharma Gets Positive CHMP Opinion For XTANDI In Early Prostate Cancer Treatment Setting

Astellas Pharma Gets Positive CHMP Opinion For XTANDI In Early Prostate Cancer Treatment Setting

Astellas Pharma Inc. announced Friday the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion recommending approval of XTANDI (enzalutamide) as monotherapy or in combination with androgen deprivation therapy for the treatment of adult men with high risk biochemical recurrent (BCR) non-metastatic hormone sensitive prostate cancer (nmHSPC) who are unsuitable for salvage radiotherapy.
RTTNews | Před 353 dny
Dollar Tumbles As Trade War Ignites Growth Fears

Dollar Tumbles As Trade War Ignites Growth Fears

The U.S. dollar tumbled against major currencies during the week ended March 7 amidst an extended sell-off on Wall Street triggered by the escalation in the trade war and a weak labor market update.
RTTNews | Před 7 h 42 min
Bay Street Likely To Open On Weak Note

Bay Street Likely To Open On Weak Note

Canadian shares are likely to open on a negative note Monday morning amid fears of a U.S. recession, and rising concerns about China's growth outlook.
RTTNews | Před 8 h 7 min
Yen Rises Amid Risk Aversion

Yen Rises Amid Risk Aversion

The Japanese yen strengthened against other major currencies in the European session on Monday, as the investor sentiment fell on lingering tariff worries, the threat of a U.S. recession and signs of deepening deflationary pressures in China.
RTTNews | Před 9 h 22 min
Yen Rises Against Majors

Yen Rises Against Majors

The Japanese yen strengthened against other major currencies in the European session on Tuesday.
RTTNews | Před 10 h 28 min
FTSE 100 Slips After Positive Start, Down Nearly 0.6%

FTSE 100 Slips After Positive Start, Down Nearly 0.6%

After a positive start, U.K. stocks retreated Monday morning, with shares from banking sector recording notable losses. Concerns about the outlook for global economic growth and uncertainty about U.S. trade policy are hurting sentiment.
RTTNews | Před 10 h 35 min
Sensex, Nifty Give Up Early Gains

Sensex, Nifty Give Up Early Gains

Indian shares ended slightly lower on Monday, failing to hold early gains due to uncertainty surrounding U.S. tariffs and signs of deepening deflationary pressures in China.
RTTNews | Před 10 h 59 min